Pharma Privat GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe. Founded in 2005, the company has established itself as a leader in the development and distribution of high-quality generic medications and innovative healthcare solutions. With a focus on prescription drugs, over-the-counter products, and specialised therapies, Pharma Privat GmbH is committed to enhancing patient care through its unique offerings. The company’s dedication to quality and compliance has earned it a strong market position, recognised for its reliability and efficiency in the supply chain. Notable achievements include strategic partnerships and a robust portfolio that caters to diverse therapeutic areas, ensuring that Pharma Privat GmbH remains at the forefront of the pharmaceutical landscape.
How does Pharma Privat GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Pharma Privat GmbH's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2021, Pharma Privat GmbH reported total carbon emissions of approximately 1,487,150 kg CO2e. This figure includes Scope 1 emissions of about 27,080 kg CO2e, Scope 2 emissions of around 97,560 kg CO2e, and significant Scope 3 emissions totalling approximately 1,416,510 kg CO2e. Within Scope 3, notable contributors include purchased goods and services at about 1,007,000 kg CO2e, employee commute at approximately 333,000 kg CO2e, and business travel emissions of around 62,000 kg CO2e. Despite the substantial emissions reported, Pharma Privat GmbH has not disclosed any specific reduction targets or climate pledges. The company does not appear to inherit emissions data from a parent organisation, indicating that all reported figures are directly from its own operations. As such, the organisation is currently positioned within the industry context of increasing scrutiny on carbon footprints, yet lacks formal commitments to reduce its emissions in the near future.
Access structured emissions data, company-specific emission factors, and source documents
2021 | |
---|---|
Scope 1 | 27,080 |
Scope 2 | 97,560 |
Scope 3 | 1,416,510 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharma Privat GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.